ImmunoPrecise Antibodies (IPA) to Release Quarterly Earnings on Friday

ImmunoPrecise Antibodies (NASDAQ:IPA) is projected to release its earnings data before the market opens on Friday, March 28th. Analysts expect ImmunoPrecise Antibodies to post earnings of ($0.06) per share and revenue of $6.59 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

ImmunoPrecise Antibodies Stock Down 2.8 %

NASDAQ IPA opened at $0.43 on Thursday. The company has a quick ratio of 0.85, a current ratio of 1.01 and a debt-to-equity ratio of 0.36. ImmunoPrecise Antibodies has a fifty-two week low of $0.27 and a fifty-two week high of $1.64. The business has a 50 day moving average price of $0.44 and a two-hundred day moving average price of $0.48. The stock has a market cap of $13.28 million, a PE ratio of -0.55 and a beta of 0.09.

Analyst Ratings Changes

Separately, HC Wainwright restated a “buy” rating and issued a $7.00 target price on shares of ImmunoPrecise Antibodies in a research note on Friday, March 14th.

About ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, a positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes.